Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: A phase I study in children

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1168-1172

  Pihoker, Catherine ^a,f   Kearns, Gregory L ^b,c   French, Daniel ^d   Bowers, Cyril Y ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d PFIZER INC   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PRALMORELIN; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHARMACODYNAMICS; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PLASMA CLEARANCE; PREPUBERTY; PRIORITY JOURNAL; SHORT STATURE;

CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; GROWTH HORMONE-RELEASING HORMONE; HORMONES; HUMANS; MALE; OLIGOPEPTIDES;

SIGMOIDEA;

EID: 0031762361     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.4.1168     Document Type: Article

References (30)

1. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release GH. Endocrinology. 114:1537-1545.
2. Bowers CY, Sartor AD, Reynolds GA, Badger TM. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128:2027-2035.
3. Bowers CY. 1993 GH releasing peptides-structure and kinetics. J Pediatr Endocrinol. 6:21-31.
4. Bowers CY, Veeraragavan K, Sethumadhavan. 1994 Atypical growth hormone releasing peptides. In: Bercu BB, Walker RF, eds. Growth hormone. II. Basic and clinical aspects. New York: Springer-Verlag; 203-222.
5. Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR. 1995 GH responses to GHRP and to GHRH in GH deficient children. J Clin Endocrinol Metab. 80:1681-1684.
6. DeBell WK, Pezzoli SS, Thorner MO. 1991 GH secretion during continuous infusion of GHRP: partial response attenuation. J Clin Endocrinol Metab. 72:1312-1316.
7. Bowers CY, Alster DK, Frentz JM. 1992 The growth hormone releasing activity of synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab. 74:292-298.
8. Bercu BB, Yang S, Masuda R, Walker RF. 1992 Role of selected endogenous peptides in GHRP activity: analysis of GHRH, thyroid hormone releasing hormone, and gonadotropin-releasing hormone. Endocrinology. 130:2579-2586.
9. Saggese G, Cesaretti G, Giannessi N, Bracaloni C, Cinquanta L, Cioni C. 1992 Stimulated GH secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin. J Clin Endocrinol Metab. 74:272-278.
10. Bercu BB, Shulman D, Root AW, Spiliotis BE. 1986 Growth hormone provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab. 63:709-716.
11. Goji K. 1993 Pulsatile characteristics of spontaneous GH concentration profiles in boys evaluated by an ultrasensitive immunoradiometric assay: evidence for ultradian periodicity of GH secretion. J Clin Endocrinol Metab. 76:667-670.
12. Martin JB, Reichlin SY. 1987 Clinical neuroendocrinology. New York: Springer Verlag; 51.
13. Gelato MC, Malozowski S, Caruso-Nicoletti M, et al. 1986 GH responses to GHRH during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. J Clin Endocrinol Metab. 63:174-179.
14. Pihoker C, Middleton R, Bowers CY. 1995 Diagnostic studies with intravenous and intranasal GHRP-2 in children of short stature. J Clin Endocrinol Metab. 80:2987-2992.
15. Mericq V, Cassorla F, Salazar T, et al. Increased growth velocity during prolonged GHRP-2 administration to GH deficient children [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 85.
16. Pihoker C, Bowers CY, Middleton R, Reynolds GA, Badger TM. Treatment effects of intranasal GHRP-2 in GH deficient children [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 504.
17. Laron Z, Frenkl J, Eshet R, Klinger B, Silbergeld A. Human GH and insulin-like growth factor-1 stimulating and growth promoting effects by long term intranasal administration of the hexapeptide-hexarelin [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 504.
18. Gomeni R, Gomeni C. 1979 AUTOMOD: a polyalgorithm for an integrated analysis of linear pharmacokinetic models. Comput Biol Med. 9:38-48.
19. Marquardt DW. 1963 An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Mathemat. 11:431-441.
20. Yamaoka K, Nakagawa T, Uno T. 1978 Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 6:165-175.
21. Wagner JG. 1976 Linear pharmacokinetic equations allowing direct calculation of needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm. 4:443-467.
22. Holford NHG, Sheiner LB. 1981 Understanding the dose-effect relationship: clinical applications of the pharmacokinetic-pharmacodynamic model. Clin Pharmacokinet. 6:429-453.
23. Evans WS, Vance ML, Daiser DL, et al. 1985 Effects of intravenous, subcutaneous, and intranasal administration of GHRH-40 on serum GH concentrations in normal men. J Clin Endocrinol Metab. 61:846-850.
24. 2 and stimulation of GH secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr. 288(Suppl):10-15.
25. Kearns GL, Kemp SF, Frindik JP. 1991 Single and multiple dose pharmacokinetics of methionyl GH in children with idiopathic GH deficiency. J Clin Endocrinol Metab. 72:1148-1156.
26. Parker ML, Vtiger RD, Daughaday WH. 1962 Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man. J Clin Invest. 41:262-268.
27. Refetoff S, Sonksen PH. 1970 Disappearance rate of endogenous and exogenous human growth hormone in man. J Clin Endocrinol Metab. 30:386-392.
28. Usala AL, Blumer JL. 1989 Pharmacology of new hormonal therapies in the treatment of pediatric endocrine disorders. Pediatr Clin North Am 36:1157-1182.
29. Skamene A, Patel YC. 1984 Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones. Clin Endocrinol (Oxf). 20:555-564.
30. Kemp SF, Kearns GL, Frindik JP. 1993 Clinical and biochemical correlates of growth associated with short term administration of methionyl growth hormone. Dev Pharmacol Ther. 20:199-204.